Insulet (PODD) Receivables (2010 - 2026)

Insulet (PODD) has reported Receivables for 17 consecutive years, with $588.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Receivables rose 92.13% year-over-year to $588.7 million; the trailing twelve-month figure through Jun 2026 stood at $588.7 million (up 92.13% YoY), and the FY2025 full-year result was $516.9 million, up 104.71% from the prior year.
• Receivables grew to $588.7 million in Q2 2026 per PODD's latest filing, from $544.7 million in the prior quarter.
• Across five years, Receivables topped out at $588.7 million in Q2 2026 and bottomed at $167.6 million in Q2 2023.
• Historically, Receivables has averaged $286.8 million across 5 years, with a median of $244.6 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Receivables slipped 18.88% in 2023, then surged 104.71% in 2025.
• Over 5 years, Receivables stood at $205.6 million in 2022, then rose by 16.88% to $240.3 million in 2023, then climbed by 5.08% to $252.5 million in 2024, then soared by 104.71% to $516.9 million in 2025, then grew by 13.89% to $588.7 million in 2026.
• According to Business Quant data, Receivables over the past three periods registered $588.7 million, $544.7 million, and $516.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.